On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial

医学 心脏再同步化治疗 心脏病学 内科学 射血分数 心脏起搏 心力衰竭 捆绑 复合材料 材料科学
作者
Gaurav A. Upadhyay,Pugazhendhi Vijayaraman,Hemal M. Nayak,Nishant Verma,Gopi Dandamudi,Parikshit S. Sharma,Moeen Saleem,John Mandrola,Davide Genovese,Jess W. Oren,Faiz A. Subzposh,Zaid Aziz,Andrew D. Beaser,Dalise Y. Shatz,Stephanie A. Besser,Roberto M. Lang,Richard G. Trohman,Bradley P. Knight,Roderick Tung
出处
期刊:Heart Rhythm [Elsevier BV]
卷期号:16 (12): 1797-1807 被引量:196
标识
DOI:10.1016/j.hrthm.2019.05.009
摘要

BackgroundThe His-SYNC pilot trial was the first randomized comparison between His bundle pacing in lieu of a left ventricular lead for cardiac resynchronization therapy (His-CRT) and biventricular pacing (BiV-CRT), but was limited by high rates of crossover.ObjectiveTo evaluate the results of the His-SYNC pilot trial utilizing treatment-received (TR) and per-protocol (PP) analyses.MethodsThe His-SYNC pilot was a multicenter, prospective, single-blinded, randomized, controlled trial comparing His-CRT vs BiV-CRT in patients meeting standard indications for CRT (eg, NYHA II–IV patients with QRS >120 ms). Crossovers were required based on prespecified criteria. The primary endpoints analyzed included improvement in QRS duration, left ventricular ejection fraction (LVEF), and freedom from cardiovascular (CV) hospitalization and mortality.ResultsAmong 41 patients enrolled (aged 64 ± 13 years, 38% female, LVEF 28%, QRS 168 ± 18 ms), 21 were randomized to His-CRT and 20 to BiV-CRT. Crossover occurred in 48% of His-CRT and 26% of BiV-CRT. The most common reason for crossover from His-CRT was inability to correct QRS owing to nonspecific intraventricular conduction delay (n = 5). Patients treated with His-CRT demonstrated greater QRS narrowing compared to BiV (125 ± 22 ms vs 164 ± 25 ms [TR], P < .001;124 ± 19 ms vs 162 ± 24 ms [PP], P < .001). A trend toward higher echocardiographic response was also observed (80 vs 57% [TR], P = .14; 91% vs 54% [PP], P = .078). No significant differences in CV hospitalization or mortality were observed.ConclusionsPatients receiving His-CRT on-treatment demonstrated superior electrical resynchronization and a trend toward higher echocardiographic response than BiV-CRT. Larger prospective studies may be justifiable with refinements in patient selection and implantation techniques to minimize crossovers. The His-SYNC pilot trial was the first randomized comparison between His bundle pacing in lieu of a left ventricular lead for cardiac resynchronization therapy (His-CRT) and biventricular pacing (BiV-CRT), but was limited by high rates of crossover. To evaluate the results of the His-SYNC pilot trial utilizing treatment-received (TR) and per-protocol (PP) analyses. The His-SYNC pilot was a multicenter, prospective, single-blinded, randomized, controlled trial comparing His-CRT vs BiV-CRT in patients meeting standard indications for CRT (eg, NYHA II–IV patients with QRS >120 ms). Crossovers were required based on prespecified criteria. The primary endpoints analyzed included improvement in QRS duration, left ventricular ejection fraction (LVEF), and freedom from cardiovascular (CV) hospitalization and mortality. Among 41 patients enrolled (aged 64 ± 13 years, 38% female, LVEF 28%, QRS 168 ± 18 ms), 21 were randomized to His-CRT and 20 to BiV-CRT. Crossover occurred in 48% of His-CRT and 26% of BiV-CRT. The most common reason for crossover from His-CRT was inability to correct QRS owing to nonspecific intraventricular conduction delay (n = 5). Patients treated with His-CRT demonstrated greater QRS narrowing compared to BiV (125 ± 22 ms vs 164 ± 25 ms [TR], P < .001;124 ± 19 ms vs 162 ± 24 ms [PP], P < .001). A trend toward higher echocardiographic response was also observed (80 vs 57% [TR], P = .14; 91% vs 54% [PP], P = .078). No significant differences in CV hospitalization or mortality were observed. Patients receiving His-CRT on-treatment demonstrated superior electrical resynchronization and a trend toward higher echocardiographic response than BiV-CRT. Larger prospective studies may be justifiable with refinements in patient selection and implantation techniques to minimize crossovers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
水色发布了新的文献求助10
3秒前
lin发布了新的文献求助10
3秒前
胡须发布了新的文献求助30
3秒前
5秒前
江十三发布了新的文献求助10
8秒前
lishuang完成签到,获得积分10
8秒前
9秒前
10秒前
昵称发布了新的文献求助10
12秒前
13秒前
MaxWong完成签到,获得积分20
14秒前
TAO完成签到,获得积分10
15秒前
codwest完成签到,获得积分10
15秒前
queer发布了新的文献求助10
16秒前
18秒前
大模型应助lin采纳,获得10
20秒前
独特冰安发布了新的文献求助10
20秒前
内丹翠发布了新的文献求助10
21秒前
21秒前
h3完成签到,获得积分10
22秒前
清爽的机器猫完成签到 ,获得积分10
22秒前
独特冰安发布了新的文献求助10
23秒前
李创业发布了新的文献求助10
24秒前
华仔应助MaxWong采纳,获得10
24秒前
8R60d8应助虚幻蜗牛采纳,获得10
25秒前
jiafx发布了新的文献求助10
26秒前
h3发布了新的文献求助10
27秒前
高大的依秋完成签到,获得积分10
28秒前
mhq完成签到,获得积分20
30秒前
lin完成签到,获得积分10
30秒前
TAO发布了新的文献求助10
31秒前
无奈的白云完成签到,获得积分10
31秒前
31秒前
今后应助积极的睫毛采纳,获得10
31秒前
32秒前
32秒前
李创业完成签到,获得积分10
32秒前
我服有点黑完成签到,获得积分10
32秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975378
求助须知:如何正确求助?哪些是违规求助? 3519775
关于积分的说明 11199621
捐赠科研通 3256067
什么是DOI,文献DOI怎么找? 1798124
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305